Biomarin Pharmaceutical Inc. logo

BMRN

Biomarin Pharmaceutical Inc.

$65.43

Earnings Summary

Revenue
$745.74Mn
Net Profits
$106.08Mn
Net Profit Margins
14.22%

Highlights

Revenue:

Biomarin Pharmaceutical Inc.’s revenue jumped 27.27% since last year same period to $745.74Mn in the Q3 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated 5.23% jump in its revenue since last 3-months.

Net Profits:

Biomarin Pharmaceutical Inc.’s net profit jumped 162.72% since last year same period to $106.08Mn in the Q3 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated -1.02% fall in its net profits since last 3-months.

Net Profit Margins:

Biomarin Pharmaceutical Inc.’s net profit margin jumped 106.43% since last year same period to 14.22% in the Q3 2024. On a quarterly growth basis, Biomarin Pharmaceutical Inc. has generated -5.94% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Biomarin Pharmaceutical Inc. post its latest quarter earnings

EPS Estimate Current Quarter
0.52
EPS Estimate Current Year
0.52

Highlights

EPS Estimate Current Quarter:

Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current quarter stand at 0.52 - a 48.57% jump from last quarter’s estimates.

EPS Estimate Current Year:

Biomarin Pharmaceutical Inc.’s earning per share (EPS) estimates for the current year stand at 0.52.

Key Ratios

Key ratios of the Biomarin Pharmaceutical Inc. post its Q3 2024 earnings

Earning Per Share (EPS)
0.55

Highlights

Earning Per Share (EPS):

Biomarin Pharmaceutical Inc.’s earning per share (EPS) jumped 161.9% since last year same period to 0.55 in the Q3 2024. This indicates that the Biomarin Pharmaceutical Inc. has generated 161.9% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-04-26
0.35
0.46
31.43%
2024-10-31
0.52
0.55
5.77%
2024-08-05
0.35
0.56
60%

Discover More Earning Stocks in Health Technology Sector